Key facts
- This page summarizes Robert E. George's Form 4 filing for Moleculin Biotech, Inc. (MBRX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 09 Jun 2021, 16:25.
Robert E. George - 07 Jun 2021 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)
- Role
- Director
- Signature
- /s/ Jonathan Foster by Power of Attorney
- Issuer symbol
- MBRX
- Transactions as of
- 07 Jun 2021
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 09 Jun 2021, 16:25:01 UTC
- Next filing
- 22 Jun 2022
- SEC
- View on sec.gov
Key filing fact
Robert E. George filed Form 4 for Moleculin Biotech, Inc. (MBRX) on 09 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
MBRX
transaction
Derivative
Stock option (right to buy)
Award
- Transaction value
- Shares
- +10,000
- Change %
- +60%
- Price
- Shares after
- 26,668
- Date
- 07 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $3.95
- Footnotes
- F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. |
| F2 | The options were issued in connection with the reporting person's Board of Director service to the Company. |